Crossmark

Maintenance therapy improves the survival outcomes of patients with metastatic nasopharyngeal carcinoma responding to first-line chemotherapy: a multicentre, randomized controlled clinical study

Crossref DOI link: https://doi.org/10.1007/s00432-022-04341-2

Published Online: 2022-09-08

Published Print: 2023-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lu, Ying

Huang, Haixin

Yang, Hui

Hu, Xiaohua

Liu, Meilian

Huang, Changjie

Feng, Xianbin

Chen, Xishan

Jiang, Zhou
Clinical Trials ^BETA

Clinical trials referenced in this document:

chictr-ior-16007939 at Chinese Clinical Trial Registry

Documents that mention this clinical trial
License Information

Text and Data Mining valid from 2022-09-08

Version of Record valid from 2022-09-08
More Information

Article History

Received: 16 June 2022

Accepted: 29 August 2022

First Online: 8 September 2022

Declarations

:

: The authors have no relevant financial or non-financial interests to disclose.

: The study was reviewed and approved by the Institutional Review Board of the Fourth Affiliated Hospital of Guangxi Medical University (PJK2015221). The study was conducted according to the tenets of the Declaration of Helsinki and the Good Clinical Practice.

: Written informed consent was obtained from all participants prior to any study-related procedures.

: Not applicable.

Document is current

Any future updates will be listed below